Effects of High-Intensity Interval Training (HIIT) on Metabolic Health among Individuals with Insulin Resistance
DOI:
https://doi.org/10.12775/QS.2025.45.66460Keywords
high-intensity interval training, insulin resistance, metabolic health, glycemic control, lipid profile, blood pressureAbstract
Introduction
Insulin resistance (IR) is a key mechanism underlying metabolic syndrome, type 2 diabetes, non-alcoholic fatty liver disease, and cardiovascular disease. Its prevalence is rising worldwide, including in Poland, with many cases undiagnosed. Lifestyle strategies, especially physical activity, are essential. High-Intensity Interval Training (HIIT) has recently drawn attention as a time-efficient method with strong potential to improve metabolic health.
Aim
This study aims to evaluate the effects of HIIT on metabolic health in individuals with insulin resistance. The focus is on insulin sensitivity, glycemic control, lipid profile, blood pressure, and hepatic function, and compares HIIT with moderate-intensity continuous training (MICT).
State of Knowledge
HIIT involves repeated bouts of vigorous activity with recovery periods, usually at 80–100% of maximal heart rate. Evidence shows that it enhances glucose uptake, reduces HOMA-IR, lowers HbA1c, and improves lipid balance by decreasing LDL and raising HDL cholesterol. HIIT also reduces systolic blood pressure and improves liver parameters in non-alcoholic fatty liver disease. Benefits are often greater than or comparable to MICT, despite shorter training duration. The strongest effects occur when combined with weight reduction and dietary changes.
Summary (Conclusions)
HIIT is an effective non-pharmacological strategy for managing insulin resistance and related disorders. It improves glycemic control, lipid and blood pressure regulation, and markedly enhances insulin sensitivity. Thanks to its time efficiency and ease of integration into daily life, HIIT is a valuable therapeutic option that may significantly support prevention and treatment of insulin resistance in both clinical
References
1.Coates AM, Joyner MJ, Little JP, Jones AM, Gibala MJ. A Perspective on High-Intensity Interval Training for Performance and Health. Sports Med. 2023;53(Suppl 1):85-96.
https://doi.org/10.1007/s40279-023-01938-6
2.Seiler S. What is best practice for training intensity and duration distribution in endurance athletes? Int J Sports Physiol Perform. 2010;5(3):276-291.
https://doi.org/10.1123/ijspp.5.3.276
3.Casado A, Foster C, Bakken M, Tjelta LI. Does Lactate-Guided Threshold Interval Training within a High-Volume Low-Intensity Approach Represent the "Next Step" in the Evolution of Distance Running Training? Int J Environ Res Public Health. 2023;20(5).
https://doi.org/10.3390/ijerph20053782
4.Jamnick NA, Pettitt RW, Granata C, Pyne DB, Bishop DJ. An Examination and Critique of Current Methods to Determine Exercise Intensity. Sports Med. 2020;50(10):1729-1756.
https://doi.org/10.1007/s40279-020-01322-8
5.Jones AMaD, J. H. Limitations to submaximal exercise performance. In: Eston RaR, T., editor. Kinanthropometry and Exercise Physiology Laboratory Manual: Tests, Procedures and Data. London: Taylor & Francis Group (Imprint: Routledge); 2001. p. 235–262.
6.Jones AM, Vanhatalo A, Burnley M, Morton RH, Poole DC. Critical power: implications for determination of V˙O2max and exercise tolerance. Med Sci Sports Exerc. 2010;42(10):1876-90.
https://doi.org/10.1249/MSS.0b013e3181d9cf7f
7.Poole DC, Burnley M, Vanhatalo A, Rossiter HB, Jones AM. Critical Power: An Important Fatigue Threshold in Exercise Physiology. Med Sci Sports Exerc. 2016;48(11):2320-34.
https://doi.org/10.1249/mss.0000000000000939
8.Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, Carty C, Chaput JP, Chastin S, Chou R, Dempsey PC, DiPietro L, Ekelund U, Firth J, Friedenreich CM, Garcia L, Gichu M, Jago R, Katzmarzyk PT, Lambert E, Leitzmann M, Milton K, Ortega FB, Ranasinghe C, Stamatakis E, Tiedemann A, Troiano RP, van der Ploeg HP, Wari V, Willumsen JF. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451-62.
https://doi.org/10.1136/bjsports-2020-102955
9.Weston K.S WU, Coombes J.S. High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis. Br J Sports Med. 2014;48(16):1227-34.
https://doi.org/10.1136/bjsports-2013-092576
10.Lebovitz HE. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S135-48.
https://doi.org/10.1055/s-2001-18576
11.Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415-28.
https://doi.org/10.1016/s0140-6736(05)66378-7
12.Freeman AM, Acevedo LA, Pennings N. Insulin Resistance. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2025, StatPearls Publishing LLC.; 2025.
13.Sinaiko AR, Caprio S. Insulin resistance. J Pediatr. 2012;161(1):11-5.
https://doi.org/10.1016/j.jpeds.2012.01.012
14.Organization WH. Diabetes 2024 [Available from:
https://www.who.int/news-room/fact-sheets/detail/diabetes.
15.Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404(10467):2077-93
.https://doi.org/10.1016/s0140-6736(24)02317-1
16.Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018;20(2):12.
https://doi.org/10.1007/s11906-018-0812-z
17.Rajca A, Wojciechowska A, Śmigielski W, Drygas W, Piwońska A, Pająk A, Tykarski A, Kozakiewicz K, Kwaśniewska M, Zdrojewski T. Increase in the prevalence of metabolic syndrome in Poland: comparison of the results of the WOBASZ (2003-2005) and WOBASZ II (2013-2014) studies. Pol Arch Intern Med. 2021;131(6):520-6.
https://doi.org/10.20452/pamw.15975
18.Zdrojewski T, Bandosz P, Szpakowski Piw, Konarski R, Manikowski A, Wołkiewicz E, Jakubowski Z, Łysiak-Szydłowska W, Bautembach S, Wyrzykowski B. Prevalence of main cardiovascular risk factors in Poland: results of the NATPOL PLUS study [in Polish]. Kardiol Pol. 2004;61(Suppl 4):1-26.
19.Muntoni S, Muntoni S. Insulin resistance: pathophysiology and rationale for treatment. Ann Nutr Metab. 2011;58(1):25-36.
https://doi.org/10.1159/000323395
20.Matthaei S, Stumvoll M, Kellerer M, Häring HU. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev. 2000;21(6):585-618.
https://doi.org/10.1210/edrv.21.6.0413
21.Abdul-Ghani MA, DeFronzo RA. Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol. 2010;2010:476279.
https://doi.org/10.1155/2010/476279
22.Yazıcı D, Sezer H. Insulin Resistance, Obesity and Lipotoxicity. Adv Exp Med Biol. 2017;960:277-304.
https://doi.org/10.1007/978-3-319-48382-5_12
23.Hall C, Yu H, Choi E. Insulin receptor endocytosis in the pathophysiology of insulin resistance. Exp Mol Med. 2020;52(6):911-20.
https://doi.org/10.1038/s12276-020-0456-3
24.Garg R, Adler GK. Role of mineralocorticoid receptor in insulin resistance. Curr Opin Endocrinol Diabetes Obes. 2012;19(3):168-75.
https://doi.org/10.1097/MED.0b013e3283533955
25.Fletcher B, Lamendola C. Insulin resistance syndrome. J Cardiovasc Nurs. 2004;19(5):339-45.
https://doi.org/10.1097/00005082-200409000-00009
26.Müller-Wieland D, Kotzka J, Knebel B, Krone W. Metabolic syndrome and hypertension: pathophysiology and molecular basis of insulin resistance. Basic Res Cardiol. 1998;93 Suppl 2:131-4.
https://doi.org/10.1007/s003950050238
27.Banaszak M, Górna I, Przysławski J. Non-Pharmacological Treatments for Insulin Resistance: Effective Intervention of Plant-Based Diets-A Critical Review. Nutrients. 2022;14(7).
https://doi.org/10.3390/nu14071400
28.Papakonstantinou E, Oikonomou C, Nychas G, Dimitriadis GD. Effects of Diet, Lifestyle, Chrononutrition and Alternative Dietary Interventions on Postprandial Glycemia and Insulin Resistance. Nutrients. 2022;14(4).
https://doi.org/10.3390/nu14040823
29.Tayebi SM, Bagherian P, Bassami M, Basereh A, Ahmadabadi S. Impact of a 12‐week High‐Intensity Interval Training With Spirulina Supplementation on Insulin Resistance‐Mediated by Apo‐A,‐B, and‐J in Men With Obesity. European Journal of Sport Science. 2025;25(4):e12285
30.Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7(1):216.
https://doi.org/10.1038/s41392-022-01073-0
31.Martins FO, Conde SV. Impact of Diet Composition on Insulin Resistance. Nutrients. 2022;14(18).
https://doi.org/10.3390/nu14183716
32.Dayi T, Ozgoren M. Effects of the Mediterranean diet on the components of metabolic syndrome. J Prev Med Hyg. 2022;63(2 Suppl 3):E56-e64.
https://doi.org/10.15167/2421-4248/jpmh2022.63.2S3.2747
33.Mirabelli M, Russo D, Brunetti A. The Role of Diet on Insulin Sensitivity. Nutrients. 2020;12(10).
https://doi.org/10.3390/nu12103042
34.Herman R, Kravos NA, Jensterle M, Janež A, Dolžan V. Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport. Int J Mol Sci. 2022;23(3).
https://doi.org/10.3390/ijms23031264
35.Mitranun W, Deerochanawong C, Tanaka H, Suksom D. Continuous vs interval training on glycemic control and macro- and microvascular reactivity in type 2 diabetic patients. Scand J Med Sci Sports. 2014;24(2):e69-76.
https://doi.org/10.1111/sms.12112
36.Mucinski JM, Salvador AF, Moore MP, Fordham TM, Anderson JM, Shryack G, Cunningham RP, Lastra G, Gaballah AH, Diaz-Arias A, Ibdah JA, Rector RS, Parks EJ. Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH. J Hepatol. 2024;81(5):781-93.
https://doi.org/10.1016/j.jhep.2024.06.017
37.Ramos JS, Dalleck LC, Tjonna AE, Beetham KS, Coombes JS. The impact of high-intensity interval training versus moderate-intensity continuous training on vascular function: a systematic review and meta-analysis. Sports Med. 2015;45(5):679-92.
https://doi.org/10.1007/s40279-015-0321-z
38.Lu Y, Baker JS, Ying S, Lu Y. Effects of practical models of low-volume high-intensity interval training on glycemic control and insulin resistance in adults: a systematic review and meta-analysis of randomized controlled studies. Front Endocrinol (Lausanne). 2025;16:1481200. https://doi.org/10.3389/fendo.2025.1481200
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Zofia Kania-Bonicka, Klaudia Wojtach, Oriana Dziechciarz, Oliwia Kałwak, Barbara Głowacka, Hanna Mruzek

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 124
Number of citations: 0